Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets

• Published in: Platelets (Edinburgh) 2023-12, Vol.34 (1), p.2249549-2249549
• Main Authors: Kumar Singh, Pankaj, Dangelmaier, Carol A, Reddy Vari, Hymavathi, Tsygankov, Alexander Y, Kunapuli, Satya P
• Format: Article
• Language: English
• Subjects: alternate splicing; Amino Acid Sequence; Amino Acids; Animals; Blood Platelets; gpvi; Humans; Mice; platelets; Protein Isoforms - genetics; syk; Syk Kinase - genetics; tyrosine kinases
• ISSN: 0953-7104; 1369-1635; 1369-1635
• DOI: 10.1080/09537104.2023.2249549

Alternate splicing is among the regulatory mechanisms imparting functional diversity in proteins. Studying protein isoforms generated through alternative splicing is therefore critical for understanding protein functions in many biological systems. Spleen tyrosine kinase (Syk) plays an essential role in ITAM/hemITAM signaling in many cell types, including platelets. However, the spectrum of Syk isoforms expressed in platelets has not been characterized. Syk has been shown to have a full-length long isoform SykL and a shorter SykS lacking 23 amino acid residues within its interdomain B. Furthermore, putative isoforms lacking another 23 amino acid-long sequence or a combination of the two deletions have been postulated to exist. In this report, we demonstrate that mouse platelets express full-length SykL and the previously described shorter isoform SykS, but lack other shorter isoforms, whereas human platelets express predominantly SykL. These results both indicate a possible role of alternative splicing in the regulation of receptor signaling in mouse platelets and a difference between signaling regulation in mouse and human platelets.